The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon.

Authors :: Rustin, M. H. A.
Almond, N. E.
Beacham, J. A.
Brooks, R. J.
Jones, D. P.
Cooke, E. D.
Dowd, P. M.
Source :: British Journal of Dermatology; Dec1987, Vol. 117 Issue 6, p751-758, 8p
Publication Year :: 1987
Abstract: Fifteen patients with primary Raynaud's phenomenon received captopril 25 mg or placebo, three times daily for 6 weeks, in a randomized double-blind cross-over study. Compared with placebo, captopril produced a significant improvement in cutaneous blood flow but did not alter the frequency or severity of attacks of Raynaud's phenomenon. [ABSTRACT FROM AUTHOR]

Subjects :: RAYNAUD'S disease
PATIENTS
PLACEBOS
THERAPEUTICS
CAPTOPRIL
BLOOD flow

Full Text Access

Tools